Stroke, Ischemic
361
98
111
144
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
17 trials with published results (5%)
Research Maturity
144 completed trials (40% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.0%
11 terminated out of 361 trials
92.9%
+6.3% vs benchmark
9%
31 trials in Phase 3/4
12%
17 of 144 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 144 completed trials
Clinical Trials (361)
Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke
Evaluation of the Effectiveness and Safety of Keeogo™ Dermoskeleton in Subjects With Mobility Impairments Due to Stroke
Virtual Physical Activity Seated Exercise - Phase 2
The Fourth Left Atrial Appendage Occlusion Study
Pathophysiology and Risk of Atrial Fibrillation Detected After Ischemic Stroke
MR Evidence of Cardiac Inflammation Post-Stroke
Statistical Learning as a Novel Intervention for Cortical Blindness
Neurovascular Product Surveillance Registry
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)
Effect of Visual Retraining After Stroke
Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial With a Historical Control Group
Stroke Prevention in Young Adults With Sickle Cell Anemia
A Phase Ⅱb Study of XY03-EA Tablets in Acute Ischemic Stroke
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Trustworthy Artificial Intelligence for Improvement of Stroke Outcomes
Rehabilitation Program Dedicated to Post-stroke Lateropulsion Including Exoskeleton Assisted Exercises
Mechanisms of Visual Restoration After Occipital Stroke
Vision Loss Impact on Navigation in Virtual Reality